Malignant nerve sheath tumor involving glossopharyngeal, vagus and spinal nerve with intracranial-extracranial extension and systemic metastases in a patient with type 1 neurofibromatosis: A case report  by Guerra-Mora, José Raúl et al.
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INTRODUCTION:  Intracranial  malignant  peripheral  nerve  sheath  tumors  are  an extremely  rare  pathology
with  a high  morbidity  and  mortality.  Epidemiological,  clinical  and  prognostic  data  are  scarce  and  with
little  certainty  in  the  literature.  The  aim  of  this  paper  is to report  for ﬁrst time  in English  literature,  the
case  of  a patient  with  type  1  neuroﬁbromatosis,  who  presented  a  malignant  peripheral  nerve  sheath
tumor  that  involved  the  left  glossopharyngeal,  vagus  and  spinal  nerves  with  intracranial  and  extracranial
extension  through  jugular  foramen  and  systemic  metastases.
PRESENTATION  OF  CASE:  A 37 years-old  female  patient  with  malnutrition  and  Villaretı´s  syndrome.  It  was
conﬁrmed  by brain  magnetic  resonance  imaging  and PET-CT  the  presence  of  a neoplasic  lesion  which
was  radiologically  compatible  with  malignant  peripheral  nerve  sheath  tumor  with  systemic  metastases.
Partial  surgical  resection  was  performed;  the  patient  postoperative  course  was  without  signiﬁcant  clinicalillaret’s syndrome improvement  but with  added  peripheral  facial  palsy.  The  patient  did  not  accept  adjuvant  management
because  of personal  reasons.
DISCUSSION  AND  CONCLUSION:  Behavior  therapy  is unclear  due  to the  low  frequency  of the  disease  and
the  lack  of case  series,  representing  a  challenge  for  the  physician  in  its  approach  and  a poor prognosis  for
the  patient.
© 2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Peripheral nerve sheath tumors (PNST) are histologically benign
nd slow growing lesions with an incidence of 0.001% in gen-
ral population [1]. Schwannomas and neuroﬁbromas represent
he vast majority, being up to 10–12% of this benign neoplasm of
onnective tissue [2]. There is an increased risk of malignant trans-
ormation in genetically susceptible patients such as patients with
ype 1 neuroﬁbromatosis (NF1), resulting in a malignant peripheral
erve sheath tumor (MPNST), which can occur rarely at any nerve
oot including cranial nerves. Current literature reports about 40
ases in the English-written journals and periodicals, the most fre-
uently affected cranial nerves are in decreasing order of frequency
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the trigeminal and vestibulocochlear – facial complex [1,3–5] and in
one case the lower cranial nerves complex through jugular foramen
in a pediatric patient [6].
The objective of this manuscript is to report for the ﬁrst time in
the English-written literature the case of an adult female patient
with NF1 who presented a MPNST involving the glossopharyngeal,
vagus and spinal left nerves which extended from the left cerebello-
pontine cistern to C4–C5 levels via the jugular foramen, along with
this primary lesion the patient presented systemic metastases.
2. Case report
2.1. Clinical history, physical examination and imageA 37-year-old female presented with the following relevant
prior medical history: NF1 diagnosed eight years ago, neuroﬁbroma
resection at ﬁrst left metacarpophalangeal joint six years ago.
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Preoperative brain MRI  showing a hyperintense neoplastic lesion on T2 sequence at left cerebellopontine cistern (A) with extension to C4-C5 level through jugular
foramen (B and C), it enhances at gadolinium administration (D–F) and shows a low signal intensity in the center (E and F).
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aig. 2. PET-CT. Coronal, sagittal and axial sections showing metastatic lesions (arro
etabolism of 5-ﬂuorodeoxyglucose.
The patient sought medical attention through his primary care
hysician (PCP) with a chief complaint of one-month history
f hoarseness accompanied with nonproductive cough, she was
reated with a 7-day antibiotic course with no successful results,
eason why the PCP referred the patient to otolaryngology where
he was diagnosed as chronic pharyngitis and put on a 2-month
ntibiotic course without improvement, further analysis of the case paravertebral (A–C), pelvic (A and D) and left thigh levels (A and E) with increased
was done by the otolaryngologist, including laryngoscopy which
revealed a left vocal cord paralysis. Magnetic resonance imaging
(MRI) of the brain and cervical spine were ordered and the patient
was ultimately referred to the neurology and neurosurgery depart-
ment of our hospital.
At hospital admission she referred a history of fatigue, weak-
ness, dysphagia to solids and weight loss of 8 kg in the last 6 months.
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Fig. 3. Macroscopic appearance. The specimen has an irregular shape, measuring 7.3 × 1.3 × 7 cm.  It is solid, heterogenous, yellowish brown with areas of necrosis and
hemorrhage and rubbery consistency (A). Small specimens with homogeneous solid appearance, whitish, yellow and soft rubbery consistencies were observed (B and C).
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tig. 4. Histopathology. High cellularity (A), pleomorphic spindled cells, abnormal m
mmunohistochemistry for protein S-100 was strongly positive in neoplastic cells (
hysical examination revealed a cachectic patient with a body mass
ndex of 16.4 kg/m [2], along the skin there were multiple café au lait
pots wider than 1.5 cm in diameter, as well as widely disseminated
phelides with axillary and scapular predominance and multiple
utaneous neuroﬁbromas; the main ﬁnding during physical exam-
nation was a solid mass, mobile and painless about 5 × 5 × 3 cm,
raversing the left carotid and occipital neck triangle. At neuro-
ogical examination positive ﬁndings were left ptosis, right uvula
eviation, left soft palate veil drop, limitation for lifting left shoul-
er and head rotation to the right, hypotroﬁa of left portion of the
ongue and shift to the left at protrusion. ﬁgures (B), geographical necrotic areas (C), epitheloid cells aspect (D) are observed.
 marker Ki67 was  positive in 30% of neoplastic cells (F).
In MRI  a neoplastic aspect lesion was observed, which extended
from the left cerebellopontine cistern to C4-C5 levels through the
jugular foramen (Fig. 1). Positron emission tomography combined
with computed tomography (PET-CT) with 18-ﬂudeoxyglucose
revealed increased uptake at paravertebral levels, pelvic cavity
and left thigh (Fig. 2). In addition to the known diagnoses of type
1 neuroﬁbromatosis and malnutrition, Villaretı´s syndrome was
diagnosed secondary to neoplastic lesion at left jugular foramen,
compatible with MPNST.
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.2. Surgery
Due to disease stage and nutritional status, it was  decided only
esection of the cervical portion for diagnostic purposes. Left ante-
ior cervical approach was performed; a round mass, with greyish
olor combined with some red areas, and a stone-like aspect was
ound and resected.
Glossopharyngeal, vagus and spinal nerves were surrounded
ntirely by the tumor and dissection was deemed impossible; the
xact tumor origin could not be established. Tumor and the inner
erves were sectioned at its rostral and caudal extremes (Fig. 3).
here were no incidents during surgery.
.3. Histopathology
Histopathology reported a MPNST of the glossopharyngeal,
agus and spinal nerves with proliferation index Ki-67 30% (Fig. 4).
.4. Follow-up
After surgery, the patient was admitted immediately to the
ntensive care unit for airway protection and was  withdrawn from
echanical ventilation within the ﬁrst 24 h without complications.
ysphagia and left peripheral (House Brackmann 4) facial palsy
resented immediately after surgery. In the course of 6 months the
atient presented a slight improvement in facial movement (House
rackmann 3) with left ptosis and tongue palsy. With the aim to
reat residual tumor and spread disease, chemotherapy and radia-
ion were offered to the patient, who rejected the offered treatment
or undisclosed reasons.
. Discussion
MPNST are a rare variety of origin ectomesenquimatous sar-
oma [3], currently known under this term [7], formerly subsumed
nto different groups: neuroﬁbrosarcoma, malignant neurilemoma,
alignant schwannoma, neurogenic sarcoma, malignant neuroﬁ-
roma. It accounts for about 5–10% of soft tissue sarcomas [8],
ost commonly affecting patients between 20 and 50 years old,
redominantly in males, about 80% [9]. Frequency of localiza-
ion in decreasing order are in limbs, trunk and retroperitoneum,
arely at intracranial level with about 40 cases reported in the
nglish-written literature [1,10–16], of these, 31% may  be pre-
ented as malignant progression of a schwannoma [1,17]. About
6% of patients with these tumors are associated with NF 1 [3] and
ave a risk from 8 to 13% of presenting a MPNST over the life [1],
s happened in our patient.
In our case the patient was referred with an approximate delay
n diagnosis of 4 months, since she ﬁrst sought CPC attention.
hen admitted to hospitalization by the neurosurgery and neurol-
gy service, the following diagnosis were made: NF1, malnutrition,
eft Villaretı´s syndrome (Horner syndrome and glossopharyngeal,
agus, spinal, hypoglossal nerves palsy); diagnostics that indicate
he presence of a malignant lesion at parotid space with jugular
oramen and paravertebral extension as observed in imaging stud-
es, speciﬁcally in PET-CT.
It was decided to make a partial resection in order to alleviate
ome of the symptoms caused by mass effect and taking into con-
ideration her poor nutritional state and the stage of disease (Fig. 2)
t was deemed that total resection probably would not have ben-
ﬁted quality of life and mortality in our patient, even if radiation
herapy and chemotherapy had been accepted [1].Section of glossopharyngeal, vagus and spinal nerves at its ros-
ral and caudal portions was considered necessary since there were
o identiﬁable differentiation of tumor and nerves under the micro-
cope.PEN  ACCESS
 Surgery Case Reports 29 (2016) 196–200 199
Ki-67 was  expressed in 30% of tumor cells, which is associated
with a poor prognosis [19]. The use of chemotherapy could improve
survival [8]; however, the patient decided for personal reasons to
refuse treatment.
There are few data in the literature about management of
MPNST of cranial nerves, so it is debatable, based on the experience
of the neurosurgeon and whenever it is possible, trying to get com-
plete resections and free margins [1], which is why we  advocate for
individualization of each case according to disease extension and
patient desires. The prognosis in patients with NF1 is poor with 23%
survival at 5 years [5], linked to the frequency of metastasis.
The patient showed metastases in multiple locations outside
of the central nervous system, this phenomenon has not been
reported in literature before [1]. This remains the importance of
systemic extension studies like PET-CT in this kind of patients [20].
In a study that analyzed the factors that were associated with
prognosis, it was  found that a previous radiation and positive mar-
gins status of resection site were associated with a shorter survival
when the disease was localized; likewise, the size, grade and his-
tologic subtype were related to poor prognosis when there was
metastatic disease [17].
There are few reports in the literature of MPNST involving the
lower cranial nerves in the cervical level with intracranial and
extracranial components [10], one in a pediatric patient [6], and
another in an adult patient in Japanese literature [16].
4. Conclusion
We report the ﬁrst case in English-written literature of an adult
patient with NF1 and a MPNST with intracranial and extracraneal
extension through the jugular foramen and systemic metastasis.
Through this case we  can ascertain there is mandatory to discard
systemic disease extension at time of diagnosis in these patients.
Treatment strategies for this particular pathology are still
unclear due to the low frequency of the disease and a lack of number
of cases, making them a challenge for the neurosurgeon.
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